PHIO · Phio Pharmaceuticals Corp.
$1.13
+0.01 (+0.89%)
At close · Aug 28
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“The Company has limited cash resources, has incurred recurring operating losses and negative cash flows from its operations since its inception and has not yet recognized any product revenues. These factors have previously raised doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$13.13M
Shares
11.62M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-11-12 | New | Biotechnology | $25,931,342 | $1,415,796 | 06b |
| 2025-08-04 | New | Biotechnology | $5,080,826 | $232,149 | 06b |
| 2025-01-28 | New | Biotechnology | $6,382,020 | $265,918 | 06b |
| 2025-01-28 | New | Biotechnology | $3,660,000 | $152,500 | 06b |
| 2025-01-28 | New | Biotechnology | $5,000,010 | $208,334 | 06b |
| 2025-01-07 | New | Biotechnology | $480,000 | $30,000 | 06b |
| 2025-01-03 | New | Biotechnology | $1,314,650 | $54,649 | 06b |
| 2024-07-24 | New | Biotechnology | $6,358,543 | $136,322 | 06b |
| 2023-12-19 | New | Biotechnology | $5,399,124 | $532,563 | 06b |
| 2023-06-13 | New | Biotechnology | $10,907,728 | $2,999,373 | 06b |
| 2023-05-02 | New | Biotechnology | $4,010,519 | $4,010,519 | 06b |
| 2022-11-23 | New | Biotechnology | $1,750 | $1,750 | 06b |
| 2021-02-16 | New | Pharmaceuticals | $24,264,137 | $14,001,909 | 06b |
| 2020-04-14 | New | Pharmaceuticals | $4,375,011 | $4,375,011 | 06b |
| 2020-02-24 | New | Pharmaceuticals | $1,903,128 | $1,903,128 | 06b |
Showing 1–15 of 15 filings